LFCR
Price
$5.31
Change
+$0.14 (+2.71%)
Updated
Mar 28, 6:59 PM EST
5 days until earnings call
SCTL
Price
$1.08
Change
-$0.01 (-0.92%)
Updated
Mar 28, 6:59 PM EST
40 days until earnings call
Ad is loading...

LFCR vs SCTL ᐉ Comparison: Which is Better to Invest?

Header iconLFCR vs SCTL Comparison
Open Charts LFCR vs SCTLBanner chart's image
Lifecore Biomedical
Price$5.31
Change+$0.14 (+2.71%)
Volume$96.74K
CapitalizationN/A
Societal CDMO
Price$1.08
Change-$0.01 (-0.92%)
Volume$404.3K
CapitalizationN/A
View a ticker or compare two or three
LFCR vs SCTL Comparison Chart

Loading...

LFCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SCTLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
LFCR vs. SCTL commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Hold and SCTL is a StrongSell.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (LFCR: $5.32 vs. SCTL: $1.08)
Brand notoriety: LFCR and SCTL are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: LFCR: 77% vs. SCTL: 74%
Market capitalization -- LFCR: $162.51M vs. SCTL: $114.15M
LFCR [@Pharmaceuticals: Other] is valued at $162.51M. SCTL’s [@Pharmaceuticals: Other] market capitalization is $114.15M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whileSCTL’s FA Score has 0 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • SCTL’s FA Score: 0 green, 5 red.
According to our system of comparison, LFCR is a better buy in the long-term than SCTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 4 TA indicator(s) are bullish while SCTL’s TA Score has 2 bullish TA indicator(s).

  • LFCR’s TA Score: 4 bullish, 6 bearish.
  • SCTL’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, LFCR is a better buy in the short-term than SCTL.

Price Growth

LFCR (@Pharmaceuticals: Other) experienced а +5.56% price change this week, while SCTL (@Pharmaceuticals: Other) price change was +1.89% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +7.96%. For the same industry, the average monthly price growth was +4.60%, and the average quarterly price growth was +16.17%.

Reported Earning Dates

LFCR is expected to report earnings on Jul 30, 2024.

SCTL is expected to report earnings on May 08, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+7.96% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for LFCR with price predictions.
OPEN
A.I.dvisor published
a Summary for SCTL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
LFCR($158M) has a higher market cap than SCTL($114M). SCTL YTD gains are higher at: 208.131 vs. LFCR (-14.216). SCTL has higher annual earnings (EBITDA): -763K vs. LFCR (-22.64M). SCTL has more cash in the bank: 8.16M vs. LFCR (4.22M). SCTL has less debt than LFCR: SCTL (42.7M) vs LFCR (157M). LFCR has higher revenues than SCTL: LFCR (188M) vs SCTL (91.2M).
LFCRSCTLLFCR / SCTL
Capitalization158M114M139%
EBITDA-22.64M-763K2,967%
Gain YTD-14.216208.131-7%
P/E RatioN/AN/A-
Revenue188M91.2M206%
Total Cash4.22M8.16M52%
Total Debt157M42.7M368%
FUNDAMENTALS RATINGS
LFCR vs SCTL: Fundamental Ratings
LFCR
SCTL
OUTLOOK RATING
1..100
325
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
5034
P/E GROWTH RATING
1..100
187
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCTL's Valuation (86) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that SCTL’s stock grew similarly to LFCR’s over the last 12 months.

SCTL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that SCTL’s stock grew similarly to LFCR’s over the last 12 months.

SCTL's SMR Rating (97) in the Biotechnology industry is in the same range as LFCR (97) in the Industrial Specialties industry. This means that SCTL’s stock grew similarly to LFCR’s over the last 12 months.

SCTL's Price Growth Rating (34) in the Biotechnology industry is in the same range as LFCR (50) in the Industrial Specialties industry. This means that SCTL’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's P/E Growth Rating (1) in the Industrial Specialties industry is significantly better than the same rating for SCTL (87) in the Biotechnology industry. This means that LFCR’s stock grew significantly faster than SCTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRSCTL
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
72%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
76%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
LFCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SCTLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSMAX11.96N/A
N/A
Hartford Small Cap Value A
RYAZX198.94N/A
N/A
Rydex S&P SmallCap 600 Pure Value H
JIEZX19.79N/A
N/A
JPMorgan International Equity R2
CVFCX14.40N/A
N/A
Pioneer Disciplined Value A
GSMSX35.18N/A
N/A
Goldman Sachs Mid Cap Value Svc

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+2.51%
SHPH - LFCR
32%
Poorly correlated
-3.33%
CRON - LFCR
29%
Poorly correlated
-3.33%
CGC - LFCR
28%
Poorly correlated
-9.73%
TLRY - LFCR
27%
Poorly correlated
-0.40%
OGI - LFCR
26%
Poorly correlated
-6.32%
More